All In Biotech

Drug Trial Radar · NCT01348152

Effect of TU-100 in Patients With Functional Constipation

A Randomized, Double-Blinded, Placebo-Controlled Exploratory Study of Daikenchuto (TU-100) in Patients With Functional Constipation

Last checked: Nov 19, 2026Latest source record: Sep 17, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

50

Actual

Start

Sep 2011

Primary completion

Jul 2013

Study completion Jul 2013

Sponsor

Lead sponsor
Tsumura USAIndustry
Sponsor type
Industry
Collaborators
Cato Research
First posted
May 5, 2011

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this study is to evaluate the improvement in the severity of constipation (from Baseline to Day 28), determined by the constipation severity instrument (CSI) score \[1\], compared to placebo, following a total daily oral dose of 15 g TU-100 administered for 28 consecutive days in adult subjects with functional constipation.

Conditions

  • Functional Constipation

Interventions

  • DAIKENCHUTO (TU-100)Drug

    Subjects will be randomized to 15 g/day of TU-100. Dosage is granule. Subjects will ingest two 2.5 g doses of TU-100 three times daily for 34 consecutive days.

  • PlaceboDrug

    Subjects will be randomized to 15 g/day of placebo. Dosage is granule. Subjects will ingest two 2.5 g doses of placebo three times daily for 34 consecutive days.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline to Day 28 in CSI total scoreTime frame: Up to 10 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Colon and Rectal Surgery Associates

    Minneapolis, Minnesota

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.